drugset / Trial / NCT04341090
A Food Effect Study of Apatinib Mesylate in Healthy Subjects
RandomizedCrossoverOpen-labelOther
Summary
The primary objective of the study was to assess the effect of high-fat and low-fat meal on the pharmacokinetics of apatinib mesylate in Chinese adult healthy subjects. The secondary objective of the study was to assess the safety of apatinib mesylate administered in adult healthy subjects.
Timeline
- Start
- 2020-05-13
- Primary completion
- 2020-07-06
- Completion
- 2020-07-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | 250 mg | — |
Indications
No indication recorded.